M Bernstein1, N Laperriere, J Glen
1Division of Neurosurgery, Toronto Hospital, Ontario, Canada.
Interstitial brachytherapy offers a modest survival benefit for recurrent malignant astrocytoma patients. However, significant complications and frequent recurrence outside the treatment area necessitate careful patient selection.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: